John Overdeck’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-18,700
Closed -$602K 5461
2026
Q1
$602K Buy
+18,700
New +$692K ﹤0.01% 3613
2023
Q3
Sell
-9,000
Closed -$229K 3235
2023
Q2
$229K Sell
9,000
-29,330
-77% -$711K ﹤0.01% 2605
2023
Q1
$855K Sell
38,330
-50,740
-57% -$1.23M ﹤0.01% 1950
2022
Q4
$2.11M Sell
89,070
-62,216
-41% -$1.45M 0.01% 1300
2022
Q3
$2.51M Buy
+151,286
New +$3.4M 0.01% 1036
2021
Q3
Sell
-397,694
Closed -$15.9M 4748
2021
Q2
$15.9M Buy
397,694
+346,194
+672% +$14.8M 0.04% 590
2021
Q1
$2.77M Buy
+51,500
New +$2.97M 0.01% 1451
2019
Q4
Sell
-55,763
Closed -$1.34M 4006
2019
Q3
$1.34M Sell
55,763
-184,274
-77% -$4.9M ﹤0.01% 1740
2019
Q2
$6.84M Sell
240,037
-84,290
-26% -$2.11M 0.02% 756
2019
Q1
$8.12M Buy
324,327
+19,972
+7% +$381K 0.03% 746
2018
Q4
$3.83M Sell
304,355
-1,929
-0.6% -$22.8K 0.02% 929
2018
Q3
$2.92M Buy
306,284
+239,262
+357% +$2.64M 0.01% 1225
2018
Q2
$626K Buy
+67,022
New +$471K ﹤0.01% 2491
2018
Q1
Sell
-46,928
Closed -$306K 3538
2017
Q4
$306K Sell
46,928
-29,576
-39% -$220K ﹤0.01% 2728
2017
Q3
$671K Buy
76,504
+47,067
+160% +$383K ﹤0.01% 1967
2017
Q2
$245K Sell
29,437
-87,260
-75% -$712K ﹤0.01% 2720
2017
Q1
$1.07M Buy
116,697
+79,817
+216% +$653K ﹤0.01% 1883
2016
Q4
$285K Buy
+36,880
New +$276K ﹤0.01% 2771
2014
Q4
Sell
-26,503
Closed -$258K 2403
2014
Q3
$258K Buy
+26,503
New +$348K ﹤0.01% 1521

Other funds holding VCYT

John Overdeck's VCYT Position: Q2 2026 in Review

John Overdeck sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 18,700 shares — an estimated $602K sold.

John Overdeck first reported a position in VCYT in Q3 2014 and held it in 19 quarters. The position peaked at $15.9M in Q2 2021. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • John Overdeck reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 18,700 Veracyte shares in Q2 2026, an estimated $602K.
  • John Overdeck first reported a position in Veracyte in Q3 2014 and held it in 19 quarters.
  • John Overdeck's Veracyte position peaked at $15.9M in Q2 2021.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.